Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-06

Clinical Trial Update: A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures With the T2 Alpha Tibia Nailing System

View source ↗

Summary

A post-market clinical evaluation of the T2 Alpha Tibia Nailing System for tibial fractures has completed, with results posted on 2025-01-06.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • T2 Alpha Tibia Nailing System (tibia intramedullary nail system)

Snippet

Sponsor: Stryker Trauma and Extremities | Conditions: Tibial Fractures | Status: COMPLETED | Results posted: 2025-01-06